Literature DB >> 18573675

Acute respiratory failure due to Pneumocystis pneumonia: outcome and prognostic factors.

Viboon Boonsarngsuk1, Supinda Sirilak, Sumalee Kiatboonsri.   

Abstract

OBJECTIVES: To examine the outcome and prognostic factors of in-hospital mortality in patients with acute respiratory failure (ARF) caused by Pneumocystis pneumonia (PCP) admitted to a medical intensive care unit.
METHODS: A retrospective review was conducted of all patients with ARF from PCP in Ramathibodi Hospital between 2000 and 2006. Patient characteristics, clinical presentation, and laboratory, radiological and microbiological findings, as well as therapy and clinical course were included in the analysis of prognostic factors of death.
RESULTS: A total of 14 HIV-infected and 30 otherwise immunosuppressed patients were identified. The overall mortality rate was 63.6%. Logistic regression analysis demonstrated that APACHE II score on day 1 and level of PEEP used on day 3 of respiratory failure were associated with higher hospital mortality. In a comparison between the HIV group and the non-HIV group, the early mortality rate was significantly higher in the HIV group, but late hospital mortality was not different between the two groups. Using a univariate logistic regression model, four parameters were found to be significantly associated with death in the HIV group: sex, APACHE II score on day 1, CMV co-infection, and level of PEEP on day 3 of ARF. In the non-HIV group, corticosteroid use prior to diagnosis of PCP and level of PEEP on day 3 of ARF were found to be the significant parameters.
CONCLUSION: The mortality rate in patients with ARF caused by PCP was high. Various variable factors were related to a poor prognosis. For improved survival, multimodality treatments are needed to reduce these risk factors.

Entities:  

Mesh:

Year:  2008        PMID: 18573675     DOI: 10.1016/j.ijid.2008.03.027

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  20 in total

1.  A Pneumocystis jirovecii pneumonia outbreak in a single kidney-transplant center: role of cytomegalovirus co-infection.

Authors:  R U Pliquett; A Asbe-Vollkopf; P M Hauser; L L Presti; K P Hunfeld; A Berger; E H Scheuermann; O Jung; H Geiger; I A Hauser
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-03-09       Impact factor: 3.267

2.  Impact of HIV Infection Status on Interpretation of Quantitative PCR for Detection of Pneumocystis jirovecii.

Authors:  M Louis; J Guitard; M Jodar; T Ancelle; D Magne; O Lascols; C Hennequin
Journal:  J Clin Microbiol       Date:  2015-10-14       Impact factor: 5.948

3.  B cells modulate systemic responses to Pneumocystis murina lung infection and protect on-demand hematopoiesis via T cell-independent innate mechanisms when type I interferon signaling is absent.

Authors:  Teri R Hoyt; Erin Dobrinen; Irina Kochetkova; Nicole Meissner
Journal:  Infect Immun       Date:  2014-12-01       Impact factor: 3.441

4.  Efficacy of caspofungin combined with trimethoprim/sulfamethoxazole as first-line therapy to treat non-HIV patients with severe pneumocystis pneumonia.

Authors:  Gensheng Zhang; Miaomiao Chen; Shufang Zhang; Hongwei Zhou; Xiaozhen Ji; Jiachang Cai; Tianzheng Lou; Wei Cui; Ning Zhang
Journal:  Exp Ther Med       Date:  2017-11-16       Impact factor: 2.447

5.  In vitro and in vivo activity of iclaprim, a diaminopyrimidine compound and potential therapeutic alternative against Pneumocystis pneumonia.

Authors:  E M Aliouat; E Dei-Cas; N Gantois; M Pottier; C Pinçon; S Hawser; A Lier; D B Huang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-01-12       Impact factor: 3.267

6.  Echinocandins for Pneumocystis jirovecii pneumonia in non-HIV patients: A case report.

Authors:  Hui-Bin Huang; Jing-Min Peng; Bin Du
Journal:  Exp Ther Med       Date:  2018-08-07       Impact factor: 2.447

7.  Pulmonary coinfection by Pneumocystis jiroveci and Cryptococcus neoformans.

Authors:  Bava Javier; Lloveras Susana; Garro Santiago; Troncoso Alcides
Journal:  Asian Pac J Trop Biomed       Date:  2012-01

Review 8.  Pneumocystis jirovecii pneumonia in developing countries.

Authors:  Y de Armas Rodríguez; G Wissmann; A L Müller; M A Pederiva; M C Brum; R L Brackmann; V Capó de Paz; E J Calderón
Journal:  Parasite       Date:  2011-08       Impact factor: 3.000

9.  Missed opportunity to diagnose HIV with Pneumocystis carinii pneumonia as its sequela.

Authors:  Louise Dunphy; Neil Patel; Bret Palmer; Edward McKeown
Journal:  BMJ Case Rep       Date:  2020-06-24

Review 10.  Extra corporeal membrane oxygenation to facilitate lung protective ventilation and prevent ventilator-induced lung injury in severe Pneumocystis pneumonia with pneumomediastinum: a case report and short literature review.

Authors:  Husain Shabbir Ali; Ibrahim Fawzy Hassan; Saibu George
Journal:  BMC Pulm Med       Date:  2016-04-14       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.